374
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 Mpro

ORCID Icon
Pages 13658-13674 | Received 15 May 2021, Accepted 08 Oct 2021, Published online: 22 Oct 2021

References

  • Al-Khafaji, K., Al-Duhaidahawi, D., & Taskin Tok, T. (2021). Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2. Journal of Biomolecular Structure & Dynamics, 39(9), 3387–3395.
  • Anand, K., Palm, G. J., Mesters, J. R., Siddell, S. G., Ziebuhr, J., & Hilgenfeld, R. (2002). Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. The EMBO Journal, 21(13), 3213–3224. https://doi.org/10.1093/emboj/cdf327
  • Berendsen, H. J., Postma, J. v., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
  • Caserotti, M., Girardi, P., Rubaltelli, E., Tasso, A., Lotto, L., & Gavaruzzi, T. (2021). Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Social Science & Medicine (1982), 272, 113688. https://doi.org/10.1016/j.socscimed.2021.113688
  • Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta Bio Medica: Atenei Parmensis, 91(1), 157.
  • Da Silva, A. W. S., & Vranken, W. F. (2012). ACPYPE-Antechamber python parser interface. BMC Research Notes, 5(1), 367–368. https://doi.org/10.1186/1756-0500-5-367
  • Das, S., Sarmah, S., Lyndem, S., & Singha Roy, A. (2021). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure & Dynamics, 39(9), 3347–3357.
  • DeLano, W. L. (2002). The PyMOL user’s manual (Vol. 452). DeLano Scientific.
  • Dolinsky, T. J., Nielsen, J. E., McCammon, J. A., & Baker, N. A. (2004). PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Research, 32(Web Server issue), W665–W667. https://doi.org/10.1093/nar/gkh381
  • Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020). Vaccine hesitancy: The next challenge in the fight against COVID-19. European Journal of Epidemiology, 35(8), 775–779.
  • Elseginy, S. A., Fayed, B., Hamdy, R., Mahrous, N., Mostafa, A., Almehdi, A. M., & Soliman, S. S. (2021). Promising anti-SARS-CoV-2 drugs by effective dual targeting against the viral and host proteases. Bioorganic & Medicinal Chemistry Letters, 43, 128099. https://doi.org/10.1016/j.bmcl.2021.128099
  • Eswar, N., Webb, B., Marti‐Renom, M. A., Madhusudhan, M., Eramian, D., Shen, M. y., Pieper, U., & Sali, A. (2006). Comparative protein structure modeling using Modeller. Current Protocols in Bioinformatics, 15(1), 5.6. 1–5.6. 30. https://doi.org/10.1002/0471250953.bi0506s15
  • Fourches, D., Muratov, E., & Tropsha, A. (2010). Trust, but verify: On the importance of chemical structure curation in cheminformatics and QSAR modeling research. Journal of Chemical Information and Modeling, 50(7), 1189–1204. https://doi.org/10.1021/ci100176x
  • Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., & Martinez, A. (2020). COVID-19: Drug targets and potential treatments. Journal of Medicinal Chemistry, 63(21), 12359–12386. https://doi.org/10.1021/acs.jmedchem.0c00606
  • Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38.
  • Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012). ZINC: A free tool to discover chemistry for biology. Journal of Chemical Information and Modeling, 52(7), 1757–1768. https://doi.org/10.1021/ci3001277
  • Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., & Peng, C. (2020). Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582, 1–5.
  • Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
  • Kesselheim, A. S., Darrow, J. J., Kulldorff, M., Brown, B. L., Mitra-Majumdar, M., Lee, C. C., Moneer, O., & Avorn, J. (2021). An overview of vaccine development, approval, and regulation, with implications for COVID-19: Analysis reviews the Food and Drug Administration's critical vaccine approval role with implications for COVID-19 vaccines. Health Affairs, 40(1), 25–32. https://doi.org/10.1377/hlthaff.2020.01620
  • Kuhn, B., Gerber, P., Schulz-Gasch, T., & Stahl, M. (2005). Validation and use of the MM-PBSA approach for drug discovery. Journal of Medicinal Chemistry, 48(12), 4040–4048. https://doi.org/10.1021/jm049081q
  • Li, X., Chen, L., Cheng, F., Wu, Z., Bian, H., Xu, C., Li, W., Liu, G., Shen, X., & Tang, Y. (2014). In silico prediction of chemical acute oral toxicity using multi-classification methods. Journal of Chemical Information and Modeling, 54(4), 1061–1069. https://doi.org/10.1021/ci5000467
  • Lindorff‐Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins, 78(8), 1950–1958. https://doi.org/10.1002/prot.22711
  • Lipinski, C. A. (2004). Lead-and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
  • Luo, R., David, L., & Gilson, M. K. (2002). Accelerated Poisson–Boltzmann calculations for static and dynamic systems. Journal of Computational Chemistry, 23(13), 1244–1253.
  • Manhas, A., Lone, M. Y., & Jha, P. C. (2017). Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: An efficient strategy for the identification of novel inhibitors of PfDHODH. Journal of Molecular Graphics & Modelling, 75, 413–423.
  • Martineau, M., McIntosh-Smith, S., & Gaudin, W. (2016). Evaluating OpenMP 4.0's effectiveness as a heterogeneous parallel programming model. Paper presented at 2016 IEEE International Parallel and Distributed Processing Symposium Workshops (IPDPSW) (338–347), IEEE.
  • McIntosh-Smith, S., Price, J., Sessions, R. B., & Ibarra, A. A. (2015). High performance in silico virtual drug screening on many-core processors. The International Journal of High Performance Computing Applications, 29(2), 119–134. https://doi.org/10.1177/1094342014528252
  • Miller, B. R., III, McGee, T. D., Jr, Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA. py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321.
  • Mittal, L., Kumari, A., Srivastava, M., Singh, M., & Asthana, S. (2020). Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. Journal of Biomolecular Structure and Dynamics, 1–19.
  • Murphy, J., Vallières, F., Bentall, R. P., Shevlin, M., McBride, O., Hartman, T. K., McKay, R., Bennett, K., Mason, L., Gibson-Miller, J., Levita, L., Martinez, A. P., Stocks, T. V. A., Karatzias, T., & Hyland, P. (2021). Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nature Communications, 12(1), 1–15. https://doi.org/10.1038/s41467-020-20226-9
  • Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582–6594. https://doi.org/10.1021/jm300687e
  • Osipiuk, J., Azizi, S.-A., Dvorkin, S., Endres, M., Jedrzejczak, R., Jones, K. A., Kang, S., Kathayat, R. S., Kim, Y., Lisnyak, V. G., Maki, S. L., Nicolaescu, V., Taylor, C. A., Tesar, C., Zhang, Y.-A., Zhou, Z., Randall, G., Michalska, K., Snyder, S. A., Dickinson, B. C., & Joachimiak, A. (2021). Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nature Communications, 12(1), 1–9. https://doi.org/10.1038/s41467-021-21060-3
  • Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
  • Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
  • Pires, M. M., Silvestro, D., & Quental, T. B. (2017). Interactions within and between clades shaped the diversification of terrestrial carnivores. Evolution; International Journal of Organic Evolution, 71(7), 1855–1864.
  • Principi, N., & Esposito, S. (2020). Chloroquine or hydroxychloroquine for prophylaxis of COVID-19. Lancet Infectious Diseases, 20(10), 1118. https://doi.org/10.1016/S1473-3099(20)30296-6
  • Rut, W., Lv, Z., Zmudzinski, M., Patchett, S., Nayak, D., Snipas, S. J., El Oualid, F., Huang, T. T., Bekes, M., Drag, M., & Olsen, S. K. (2020). Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design. Science Advances, 6(42), eabd4596. https://doi.org/10.1126/sciadv.abd4596
  • Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA, 323(18), 1824–1836. https://doi.org/10.1001/jama.2020.6019
  • Shi, J., & Song, J. (2006). The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. The FEBS Journal, 273(5), 1035–1045. https://doi.org/10.1111/j.1742-4658.2006.05130.x
  • Somboon, T., Mahalapbutr, P., Sanachai, K., Maitarad, P., Lee, V. S., Hannongbua, S., & Rungrotmongkol, T. (2021). Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease. Journal of Molecular Liquids, 322, 114999. https://doi.org/10.1016/j.molliq.2020.114999
  • Thorlund, K., Dron, L., Park, J., Hsu, G., Forrest, J. I., & Mills, E. J. (2020). A real-time dashboard of clinical trials for COVID-19. The Lancet. Digital Health, 2(6), e286–e287.
  • Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Lee, D.-H., Shioda, T., Soto, A. M., Vom Saal, F. S., Welshons, W. V., Zoeller, R. T., & Myers, J. P. (2012). Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses. Endocrine Reviews, 33(3), 378–455.
  • Wang, J. (2020). Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. Journal of Chemical Information and Modeling, 60(6), 3277–3286. https://doi.org/10.1021/acs.jcim.0c00179
  • Wang, H., Dommert, F., & Holm, C. (2010). Optimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiency. The Journal of Chemical Physics, 133(3), 034117.
  • Wang, E., Sun, H., Wang, J., Wang, Z., Liu, H., Zhang, J. Z., & Hou, T. (2019). End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chemical Reviews, 119(16), 9478–9508. https://doi.org/10.1021/acs.chemrev.9b00055
  • Zhang, D., Lin, Y., Chen, X., Zhao, W., Chen, D., Gao, M., Wang, Q., Wang, B., Huang, H., Lu, Y., & Lu, Y. (2019). Docking-and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold. Bioorganic Chemistry, 85, 229–239.
  • Zhang, L., Lin, D., Kusov, Y., Nian, Y., Ma, Q., Wang, J., von Brunn, A., Leyssen, P., Lanko, K., Neyts, J., de Wilde, A., Snijder, E. J., Liu, H., & Hilgenfeld, R. (2020). α-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: Structure-based design, synthesis, and activity assessment. Journal of Medicinal Chemistry, 63(9), 4562–4578.
  • Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412.
  • Zhang, C.-H., Stone, E. A., Deshmukh, M., Ippolito, J. A., Ghahremanpour, M. M., Tirado-Rives, J., Spasov, K. A., Zhang, S., Takeo, Y., Kudalkar, S. N., Liang, Z., Isaacs, F., Lindenbach, B., Miller, S. J., Anderson, K. S., & Jorgensen, W. L. (2021). Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations. ACS Central Science, 7(3), 467–475. https://doi.org/10.1021/acscentsci.1c00039
  • Zheng, J. (2020). SARS-CoV-2: An emerging coronavirus that causes a global threat. International Journal of Biological Sciences, 16(10), 1678–1685.
  • Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., … Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.